IP Library › Granted Patent US 12,516,283
Granted Patent B2
US 12,516,283 · App. 18/329,112 · Granted Jan 6, 2026

Methods to incorporate machine learning analytics for optimizing protein purity, potency and quality in an on-demand production system for point-of-care delivery

Inventors: Govind Rao (Ellicott City, MD); Yordan Kostov (Columbia, MD); Benjamin Punshon-Smith (Gwynn Oak, MD); Rajani Adiga (Laurel, MD)
Assignee: UNIVERSITY OF MARYLAND, BALTIMORE COUNTY
C12M41/48C12M23/54C12M47/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,516,283
App. No.
18/329,112
Granted
Jan 6, 2026
Kind
B2
Abstract

The present invention relates to cell free protein manufacturing, and more particularly, for integrating machine learning into a portable cell-free bioprocessing system for producing proteins with increased and consistent purity, potency and quality wherein such proteins are prepared on-demand and for point-of-care delivery.

Claims (26)

1 . A method of analyzing and estimating purity of a protein produced in a portable, cell-free bioprocessing system, wherein the bioprocessing system comprises a protein expression module and a protein purification module, wherein each module is associated with on-board analytics, the method comprising:

producing the protein in the protein expression module;

purifying the produced protein using a two-step purification process in the protein purification module, wherein the protein purification module comprises a UV sensor for each purification process and a multiplicity of programmable syringe pumps with integrated pressure sensors positioned at a back-end of each programmable syringe pump;

obtaining at least pressure and UV sensor data from the protein purification module during purification of the produced protein;

transmitting the data to a computer aided classification system;

extracting features from the data with the computer aided classification system for classifying the produced protein and process conditions, wherein extracted features characterize the produced protein and such sample characterization is compared to characterization of extracted features from previously prepared proteins to provide classified features of the produced protein; and

applying an unsupervised clustering process to the classified features to provide a plurality of output clusters to provide an estimation of the purity of the produced protein using in-line analysis.

2 . The method of claim 1 , wherein an AI machine learning module collects and stores in-line real-time testing data of purified protein from the protein purification module and further provides information on product quality and potency for each batch of the produced proteins relative to previously produced proteins.

3 . The method of claim 1 , wherein the protein expression module comprises at least one dialysis cassette or reactor for inclusion of cell lysate, a reaction mixture, and DNA or mRNA for production of the protein.

4 . The method of claim 1 , wherein the pressure sensors and UV sensors monitor each step of the purification process.

5 . The method of claim 4 , wherein the programmable syringe pumps dispense buffers.

6 . The method of claim 3 , wherein the cell lysate is from CHO cells or E. coli cells.

7 . The method of claim 3 , wherein the reaction mixture comprises at least one of amino acids, nucleotides, co-factors, enzymes, ribosomes, tRNA, polymerases, and transcriptional factors.

8 . The method of claim 1 , wherein the protein purification module comprises a metal ion affinity chromatography column for initial purification and an ion-exchange chromatography column for a polishing step.

9 . The method of claim 4 , wherein each step of the purification process comprises an inline flow cell equipped with an inline UV sensor comprising light sources and detectors for measuring UV absorbance at about 280 nm to monitor the purification process.

10 . The method of claim 1 , further comprising measuring dissolved oxygen, pH, absorbance, pressure and temperature during the production process.

11 . The method of claim 2 , wherein the AI machine learning module uses a blind source separation (BSS) algorithm.

12 . The method of claim 11 , wherein the (BSS) algorithm uses independent-component analysis (ICA) that extracts independent source signals when the source signals are active simultaneously and is a BSS algorithm depending on using Artificial Neural Networks.

13 . The method of claim 4 , wherein each of the two purification processes comprise at least one real-time test selected from the group consisting of absorbance, circular dichroism, fluorescence measurements, and lifetime measurements.

14 . The method of claim 2 , wherein the AI machine learning module is a cloud-based server or a physical server connected to the bioprocessing system.

15 . The method of claim 1 , wherein the bioprocessing system further comprises a microfluidic mixer positioned between the protein expression module and the protein purification module to mix expressed protein with buffer.

16 . The method of claim 1 , wherein UV and pressure sensor profiles are used to detect production deviations and reject a batch of the produced protein.

17 . The method of claim 1 , wherein the bioprocessing system further comprises a processor for controlling and/or monitoring at least the protein expression module and/or the protein purification module.

18 . The method of claim 17 , wherein the processor can control a length of time in the protein expression module and/or purification module to affect potency and/or activity of the produced protein.

19 . The method of claim 1 , wherein the bioprocessing system comprises a single-use bioprocessing train comprising at least a bioreactor, tubing, at least one microfluidic mixer, a capture purification column, and a polishing purification column.

20 . The method of claim 1 , wherein the purification process comprises affinity chromatography as a first step and ion-exchange chromatography as a second step, wherein the protein purification module comprises a built-in flow cell equipped with the respective UV sensor, and wherein the pressure sensors provide continuous system pressure monitoring.

Continuity (3)
Division 17055149
Provisional Application 62671566 · May 15, 2018
Related Publication 20230407230A1 · Dec 21, 2023
References Cited (46)
US 9388373B2 · Rao et al. · 2016 [cited by applicant]
US 9982227B2 · Rao et al. · 2018 [cited by applicant]
US 10435664B2 · Rao et al. · 2019 [cited by applicant]
US 10774304B2 · Rao et al. · 2020 [cited by applicant]
US 11408898B2 · Farokhzad · 2022 [cited by examiner]
US 11685892B2 · Rao et al. · 2023 [cited by applicant]
US 20140148350A1 · Spetzler et al. · 2014 [cited by applicant]
US 20140356849A1 · Wikswo et al. · 2014 [cited by applicant]
US 20160222341A1 · Rao et al. · 2016 [cited by applicant]
US 20180038850A1 · Wang et al. · 2018 [cited by applicant]
US 20180322941A1 · Krishnan et al. · 2018 [cited by applicant]
US 20190272894A1 · Wasalathanthri · 2019 [cited by examiner]
US 20210149361A1 · Jungbauer · 2021 [cited by examiner]
WO WO2012171030A2 · 2012 [cited by applicant]
Extended European Search Report, corresponding to European Patent Application No. 19866780.0, issued on Feb. 25, 2022. [cited by applicant]
S. S. Farid, 2007, Process economics of industrial monoclonal antibody manufacture. [cited by applicant]
J. Conner et al., 2014, The Biomanufacturing of Biotechnology Products in [cited by applicant]
Finn, M. in Top Markets Series 2016 (U.S. Department of Commerce, International Trade Administration, http://trade.gov/topmarkets/pdf/Pharmaceuticals_Top_Markets_Reports). [cited by applicant]
Peñalber-Johnstone C, Ge X, Tran K, Selock N, Sardesai N, Gurramkonda C, Pilli M, Tolosa M, Tolosa L, Kostov Y, Frey DD, Rao G. 2017, Optimizing cell-free protein expression in CHO: Assessing small molecule mass transfe… [cited by applicant]
Tran K, Gurramkonda C, Cooper MA, Pilli M, Tarris J, Selock N, Han TC, Tolosa M, Zuber A, Peñalber-Johnstone C, Dinkins C, Pezeshk N, Kostov Y, Frey DD, Tolosa L, Wood D, Rao G., 2017, Cell-Free Production of a Therapeu… [cited by applicant]
G. Rao et al., 2016, Microscale bioprocessing system for therapeutic protein on-demand production. U.S. Pat. No. 9,388,373. [cited by applicant]
Adiga R, et al. Jul. 2018. Biological Medicines on Demand: A platform for therapeutic cGMP protein manufacturing at the point-of-care. [cited by applicant]
A. K. Brödel, A. Sonnabend, S. Kubick, 2014, Cell-free protein expression based on extracts from CHO cells. [cited by applicant]
C. E. Hodgman, M. C. Jewett, 2012, Cell-free synthetic biology: Thinking outside the cell. [cited by applicant]
Adamo, A. et al. 2016, On-demand continuous-flow production of pharmaceuticals in a compact, reconfigurable system. [cited by applicant]
Pardee, K. et al. 2016, Portable, on-demand biomolecular manufacturing. [cited by applicant]
Boles, K.S. et al. 2017, Digital-to-biological converter for on-demand production of biologics. [cited by applicant]
Airen IO. 2011. Genome-wide functional genomic analysis for physiological investigation and improvement of cell-free protein synthesis. Ph.D. Dissertation, Stanford University. [cited by applicant]
Guo H, Li X, Frey DD. 2014. Development of Chromatofocusing Techniques Using Mixed-Mode Column Packings for Protein Separations. [cited by applicant]
Guest DW. 1997, Evaluation of simulated moving bed chromatography for pharmaceutical process development, [cited by applicant]
Ng, C.K.S., Rousset, F., Valery, E, bracewell, D.G., Sorensen, E. 2014. Design of high productivity sequential multicolumn chromatography for antibody capture, [cited by applicant]
Ariffin, A.A.B., Hashim, U., Salam, F., Ishak, Z., Uda, M.N.A., Adam, T. 2014. COMSOL Multiphysics simulation for microfluidic separator as sample delivery system in sensing domain, Proc. Fifth Intern. Conf. Intelligent… [cited by applicant]
Ward AC, Smith L, de Koning JP, van Aesch Y, Touw IP. 1999. Multiple Signals Mediate Proliferation, Differentiation, and Survival from the Granulocyte Colony-stimulating Factor Receptor in Myeloid 32D Cells, [cited by applicant]
Panopoulos AD, Watowich SS. 2008, Granulocyte Colony-Stimulating Factor: Molecular Mechanisms of Action During Steady State and ‘Emergency’ Hematopoiesis. [cited by applicant]
Demetri GD, Griffin JD. 1991. Granulocyte colony-stimulating factor and its receptor. [cited by applicant]
Rossetti M, Gregori S, Roncarolo MG. 2010, Granulocyte-colony stimulating factor drives the in vitro differentiation of human dendritic cells that induce energy in naïve T cells. [cited by applicant]
Gurramkonda C, Mupparapu K, Abouzeid R, Kostov Y, Rao G. 2014, Fluorescence-based method and a device for rapid detection of microbial contamination. [cited by applicant]
Al-Adhami M, Tilahun D, Rao G, Gurramkonda C, Kostov Y. 2017, Rapid Detection of Microbial Contamination Using a Microfluidic Device. [cited by applicant]
Yang M, Sun S, Kostov Y, Rasooly A. 2010, Lab-On-a-Chip for carbon nanotubes based immunoassay detection of Staphylococcal Enterotoxin B (SEB). [cited by applicant]
Yang, M., Kostov, Y., Bruck, H., Rasooly, A. 2008, Carbon Nanotubes with Enhanced Chemiluminescence (CNT-ECL) Immunoassay for CCD-based Detection of Staphylococcal Enterotoxin B (SEB), [cited by applicant]
Yang, M., Kostov, Y., Rasooly, A. 2008, Carbon nanotubes based optical immunodetection of Staphylococcal Enterotoxin B (SEB) in food. [cited by applicant]
Karhunen, J, et al, 1997, A Class of Neural Networks for Independent Component Analysis, [cited by applicant]
Szu, Harold & Hsu, C., 1999, Unsupervised neural network learning for blind sources separation. 30-38. 10.1109/SBRN.1998.730990. [cited by applicant]
Caschera, F. et al., ‘Coping with complexity: machine learning optimization of cell-free protein synthesis’, Biotechnology and bioengineering. Sep. 2011, vol. 108, No. 9, pp. 2218-2228. [cited by applicant]
Caschera, F., ‘Bacterial cell-free expression technology to in vitro systems engineering and optimization’, Synthetic and systems Biotechnology, 2017, vol. 2, pp. 97-104. [cited by applicant]
Jiang, L et al., ‘Cell-free protein synthesis enabled rapid prototyping for metabolic engineering and synthetic biology’, Synthetic and systems Biotechnology, 2018, vol. 3, pp. 90-96. [cited by applicant]